Request Appointment
622 W 168th StNew York, NY 10032
Overview of Dr. Amengual
Dr. Jennifer Amengual is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from New York Medical College and has been in practice 21 years. She is one of 369 doctors at New York-Presbyterian Hospital and one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 40 publications and over 500 citings.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
New York Medical CollegeClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2007 - 2027
American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2012 Oct 31
- Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies Start of enrollment: 2013 Sep 09
- ACY-1215 for Relapsed/Refractory Lymphoid Malignancies Start of enrollment: 2014 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- HSR25-185: A Multicenter Retrospective Study of Treatment and Survival Outcomes of Patients With Secondary CNS Relapsed DLBCL in the Modern Era.Andrew L Pierce, Izel Okcu, Grzegorz Nowakowski, Seda Tolu, Jennifer Amengual
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 2 citationsGetting the right combination to break the epigenetic code.Seda S Tolu, Aaron D Viny, Jennifer E Amengual, Barbara Pro, Susan E Bates
Nature Reviews. Clinical Oncology. 2025-02-01 - Quantitation of tazemetostat in human plasma using liquid chromatography-tandem mass spectrometry.Marco Orleni, Robert A Parise, Julianne L Holleran, Jennifer E Amengual, Ye Feng
Biomedical Chromatography. 2024-07-01
Abstracts/Posters
- Strategy for Overcoming Crebbp and EP300 Mutations in Lymphoma: Development of First-in-Class HAT ActivatorsJennifer E Amengual, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 StudiesJennifer E. Amengual, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Pipeline Moves: Moderna’s Pandemic Influenza Vaccine Trial CompletesAugust 19th, 2024
Grant Support
- Columbia University Minority/Underserved Site NCI Community Oncology Research ProgramCOLUMBIA UNIVERSITY HEALTH SCIENCES2014–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
